Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Glimepiride, cis-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

88 API Suppliers, 19 USDMF, 24 CEP/COS, 8 JDMF, 13 EU WC, 35 KDMF, 10 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

558 FDF Dossiers, 72 FDA Orange Book, 230 Europe, 5 Canada, 24 Australia, 41 South Africa, 186 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 2 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 21 BASF, 6 DFE Pharma, 8 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 12 Kerry, 3 Keval Exports, 11 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 11 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 34 Disintegrants & Superdisintegrants, 27 Granulation, 25 Direct Compression, 21 Solubilizers, 16 Thickeners and Stabilizers, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Parenteral, 8 Controlled & Modified Release, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 6 Coating Systems & Additives, 5 Surfactant & Foaming Agents, 5 Topical, 5 Film Formers & Plasticizers, 4 Taste Masking, 3 Rheology Modifiers, 2 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 23 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 51 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

22 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 9 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 JP, 15 Others

ANALYTICAL

2 BioAnalytical Methods, 5 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/03/2026	EUROAPI	France	Handok Co., Ltd.	20071228-78-D-19-10	Glimepiride	2007-12-28	EUROAPI Germany GmbH	Germany	Brüningstraße 50, 65926, Frankfurt am Main, Germany
31/03/2026	Enaltec Labs	India	JL Bio Co., Ltd.	20260123-78-D-168-22	Glimepiride	2026-01-23	Enaltec Labs Private Limited	India	Plot no. 825, 826, 827, Industrial Area, Sector-3, Pithampur, Distt-Dhar, 454774, MP, India

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Glimepiride, Cis-

Glimepiride, cis-

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

88 API Suppliers

19 USDMF

24 CEP/COS

8 JDMF

13 EU WC

35 KDMF

10 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

558 FDF Dossiers

72 FDA Orange Book

230 Europe

5 Canada

24 Australia

41 South Africa

186 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

2 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

1 Dr. Paul Lohmann GmbH & Co. KGaA

2 Actylis

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

21 BASF

6 DFE Pharma

8 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

2 Ingredion Pharma Solutions

12 Kerry

3 Keval Exports

11 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

11 Roquette

6 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

10 Sigachi Industries

4 Silverline Chemicals

2 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders

34 Disintegrants & Superdisintegrants

27 Granulation

25 Direct Compression

21 Solubilizers

16 Thickeners and Stabilizers

13 Lubricants & Glidants

13 Co-Processed Excipients

10 Parenteral

8 Controlled & Modified Release

7 Chewable & Orodispersible Aids

6 Emulsifying Agents

TABLET;ORAL - 1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons